Bruno Frediani

10.4k total citations
249 papers, 4.8k citations indexed

About

Bruno Frediani is a scholar working on Rheumatology, Ophthalmology and Molecular Biology. According to data from OpenAlex, Bruno Frediani has authored 249 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Rheumatology, 50 papers in Ophthalmology and 46 papers in Molecular Biology. Recurrent topics in Bruno Frediani's work include Ocular Diseases and Behçet’s Syndrome (49 papers), Rheumatoid Arthritis Research and Therapies (42 papers) and Systemic Lupus Erythematosus Research (36 papers). Bruno Frediani is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (49 papers), Rheumatoid Arthritis Research and Therapies (42 papers) and Systemic Lupus Erythematosus Research (36 papers). Bruno Frediani collaborates with scholars based in Italy, United States and United Kingdom. Bruno Frediani's co-authors include Luca Cantarini, Mauro Galeazzi, Antonio Vitale, Donato Rigante, Georgios Filippou, Claudia Fabiani, Florenzo Iannone, Paolo Falsetti, Giuseppe Lopalco and Roberto Marcolongo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Bruno Frediani

242 papers receiving 4.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bruno Frediani 1.9k 1.2k 1.1k 957 720 249 4.8k
Mauro Galeazzi 3.8k 2.0× 1.2k 1.1× 2.0k 1.8× 620 0.6× 661 0.9× 199 7.9k
Gabriele Simonini 1.1k 0.6× 981 0.9× 1.1k 1.0× 777 0.8× 535 0.7× 229 4.0k
Yun Jong Lee 1.6k 0.8× 334 0.3× 771 0.7× 509 0.5× 467 0.6× 174 3.7k
Meral Çalgünerı 1.1k 0.6× 521 0.5× 821 0.8× 505 0.5× 594 0.8× 98 3.2k
G Triolo 2.3k 1.2× 553 0.5× 1.1k 1.0× 671 0.7× 644 0.9× 209 5.7k
Giovanni Lapadula 2.1k 1.1× 327 0.3× 521 0.5× 550 0.6× 355 0.5× 191 4.5k
Mario García‐Carrasco 2.4k 1.3× 264 0.2× 571 0.5× 707 0.7× 337 0.5× 167 5.1k
İhsan Ertenli 997 0.5× 447 0.4× 677 0.6× 331 0.3× 554 0.8× 155 2.7k
Santos Castañeda 3.1k 1.6× 152 0.1× 1.1k 1.0× 722 0.8× 1.0k 1.5× 298 5.6k
Ömer Karadağ 940 0.5× 201 0.2× 580 0.5× 517 0.5× 675 0.9× 215 2.6k

Countries citing papers authored by Bruno Frediani

Since Specialization
Citations

This map shows the geographic impact of Bruno Frediani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Frediani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Frediani more than expected).

Fields of papers citing papers by Bruno Frediani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Frediani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Frediani. The network helps show where Bruno Frediani may publish in the future.

Co-authorship network of co-authors of Bruno Frediani

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Frediani. A scholar is included among the top collaborators of Bruno Frediani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Frediani. Bruno Frediani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Onghia, Martina, Francesco Ursini, Élisa Cinotti, et al.. (2024). Psoriasis and Fibromyalgia: A Systematic Review. Journal of Personalized Medicine. 14(2). 165–165. 5 indexed citations
3.
Falsetti, Paolo, Caterina Baldi, Edoardo Conticini, et al.. (2024). Ultrasound description of cortical-entheseal bone remodeling in peripheral entheses of patients with psoriasis and nonspecific musculoskeletal symptoms. PubMed. 3(4). 277–287. 1 indexed citations
4.
Conticini, Edoardo, et al.. (2024). Impact of non-immunosuppressive medical therapy on disease progression and complications of Takayasu arteritis: A narrative review. Autoimmunity Reviews. 23(12). 103656–103656. 2 indexed citations
5.
Gaggiano, Carla, Antonio Vitale, Jurgen Sota, et al.. (2024). Systemic auto-inflammatory manifestations in patients with spondyloarthritis. Joint Bone Spine. 91(6). 105772–105772. 2 indexed citations
6.
d’Alessandro, Miriana, Edoardo Conticini, Laura Bergantini, et al.. (2024). Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease. Tissue and Cell. 90. 102516–102516.
7.
Gentileschi, Stefano, Carla Gaggiano, Arianna Damiani, et al.. (2024). Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral Centers. Journal of Personalized Medicine. 14(11). 1105–1105. 2 indexed citations
8.
Baldi, Caterina, Simone Parisi, Paolo Falsetti, et al.. (2024). Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study. Journal of Clinical Medicine. 13(2). 401–401. 5 indexed citations
9.
Fassio, Angelo, Fabiola Atzeni, Maurizio Rossini, et al.. (2023). Osteoimmunology of Spondyloarthritis. International Journal of Molecular Sciences. 24(19). 14924–14924. 3 indexed citations
10.
d’Alessandro, Miriana, Laura Bergantini, Paolo Cameli, et al.. (2022). Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II. International Journal of Environmental Research and Public Health. 19(4). 2176–2176. 6 indexed citations
11.
Varenna, M., Davide Gatti, Francesca Zucchi, et al.. (2022). Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study. Therapeutic Advances in Musculoskeletal Disease. 14. 1759720X221142274–1759720X221142274. 8 indexed citations
12.
Bergantini, Laura, Elena Bargagli, Miriana d’Alessandro, et al.. (2021). Prognostic bioindicators in severe COVID-19 patients. Cytokine. 141. 155455–155455. 35 indexed citations
13.
Varenna, M., V. Braga, Davide Gatti, et al.. (2021). Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211014020–1759720X211014020. 22 indexed citations
14.
Bennett, David, Elda De Vita, Sonia Bernazzali, et al.. (2020). Impact of SARS‐CoV‐2 outbreak on heart and lung transplant: A patient‐perspective survey. Transplant Infectious Disease. 23(1). e13428–e13428. 11 indexed citations
15.
Bennett, David, Federico Franchi, Elda De Vita, et al.. (2020). SARS-CoV-2 in pleural fluid in a kidney transplant patient. Postgraduate Medicine. 133(5). 540–543. 11 indexed citations
16.
Guerrini, Susanna, N. Giordano, Luca Volterrani, Bruno Frediani, & Maria Antonietta Mazzei. (2020). Sonozaki syndrome in the spotlight of imaging. Clinical Rheumatology. 40(3). 1193–1194.
18.
Migliore, Alberto, A Bellelli, Bruno Frediani, et al.. (2020). <p>The Technique of Intradiscal Injection: A Narrative Review</p>. Therapeutics and Clinical Risk Management. Volume 16. 953–968. 13 indexed citations
19.
Fabiani, Claudia, Antonio Vitale, Ida Orlando, et al.. (2017). Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy.. PubMed. 19(8). 478–483. 25 indexed citations
20.
Filippou, Georgios, Bruno Frediani, Adriana Gallo, et al.. (2007). CORRECTION. Annals of the Rheumatic Diseases. 66(8). 1128–1128. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026